AI Science Tracker

Machine-intelligence design yields selective synthetic COX-1 inhibitors from a marine natural-product template

ETH Zurich; Thomas Jefferson University; University of Bari; University of Innsbruck; Goethe University Frankfurt; Friedrich Schiller University Jena · 27 Jun 2021 · chemistry

Discovery

Machine-intelligence design yields selective synthetic COX-1 inhibitors from a marine natural-product template

Using Marinopyrrole A as a template, an automated design workflow generated and synthesized new natural-product-inspired molecules; target-prediction software pointed to cyclooxygenases. In biochemical assays, synthetic mimetics 2 and 2a inhibited COX-1 at 0.10 and 0.16 μM, respectively, and compound 2a was crystallographically observed bound to COX-1. Human platelet assays also showed inhibition.

Technology: DOGS rule-based de novo molecule construction and CATS molecular-similarity ranking, coupled with SPiDER self-organizing-map machine-learning target prediction

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: In biochemical assays, synthetic mimetics 2 and 2a inhibited COX-1 at 0.10 and 0.16 μM, respectively, and compound 2a was crystallographically observed bound to COX-1.
  • Still unknown: The study tests a small number of designed molecules; automated structure generation was rule-based and similarity-driven rather than a trained generative neural model. The COX-1 effects were biochemical/platelet assays, not clinical effects; the platelet IC50s for 2, 2a, 2b were 9, 13 and 56 nM, but COX-2 inhibition occurred at higher concentrations and selectivity varies by assay. Do not call these approved drugs or imply therapeutic benefit.
  • AI role: DOGS algorithmically generated natural-product-inspired structures and suggested synthetic routes; CATS ranked candidates by pharmacophore similarity. SPiDER's cascaded self-organizing-map models predicted molecular target families, including COX. Experimental target assays confirmed the previously unrecognized COX-1 activity of selected synthetic compounds, with crystallographic confirmation for compound 2a.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8373093/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 84 of works of the same type, year and subfield (OpenAlex work metrics, 31 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.